Bespoke Extracts (BSPK) Depreciation & Amortization (CF) (2023 - 2025)
Bespoke Extracts (BSPK) reported Depreciation & Amortization (CF) of $3053.0 for Q3 2025, up 16.62% on a YoY basis from $2618.0 in Q3 2024, and up 24.46% sequentially from $2453.0 in Q2 2025.
Bespoke Extracts (BSPK) Depreciation & Amortization (CF) (2023 - 2025) Analysis & Trends
Bespoke Extracts (BSPK) has 3 years of Depreciation & Amortization (CF) data on file, last reported at $3053.0 in Q3 2025.
- For the quarter ending Q3 2025, Depreciation & Amortization (CF) rose 16.62% year-over-year to $3053.0; the trailing twelve-month figure through Sep 2025 stood at $9908.0 (up 1.05% YoY), and the FY2024 full-year result was $9637.0, up 7.46% from the prior year.
- Depreciation & Amortization (CF) climbed to $3053.0 in Q3 2025, from $2453.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $3450.0 in Q1 2024 to a low of $1785.0 in Q1 2023.
- A 3-year average of $2445.1 and a median of $2617.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) soared 93.28% in 2024 and slumped 48.26% in 2025, its largest moves.
- Tracing BSPK's Depreciation & Amortization (CF) over 3 years: stood at $1785.0 in 2023, then jumped by 46.61% to $2617.0 in 2024, then climbed by 16.66% to $3053.0 in 2025.
- Business Quant data shows BSPK's Depreciation & Amortization (CF) at $3053.0 in Q3 2025, $2453.0 in Q2 2025, and $1785.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 239.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.04 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 22.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 676.10 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 172.00 Mn |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 | 3,053.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 3,053.00 |
| Sep 30, 2025 | 3,053.00 |
| Jun 30, 2025 | 2,453.00 |
| Jun 30, 2025 | 2,453.00 |
| Mar 31, 2025 | 1,785.00 |
| Mar 31, 2025 | 1,785.00 |
| Dec 31, 2024 | 2,617.00 |
| Dec 31, 2024 | 2,617.00 |
| Sep 30, 2024 | 2,618.00 |
| Sep 30, 2024 | 2,618.00 |
| Jun 30, 2024 | 1,952.00 |
| Jun 30, 2024 | 1,952.00 |
| Mar 31, 2024 | 3,450.00 |
| Mar 31, 2024 | 3,450.00 |
| Dec 31, 2023 | 1,785.00 |
| Dec 31, 2023 | 1,785.00 |
| Sep 30, 2023 | 2,617.00 |
| Sep 30, 2023 | 2,617.00 |
| Jun 30, 2023 | 2,781.00 |
| Jun 30, 2023 | 2,781.00 |